Skip to main content

Table 5 Comparison of clinicopathological factors of patients with organ confined RCC without synchronous metastases who underwent nephrectomy by cause of death

From: The impact of tumour size on the probability of synchronous metastasis and survival in renal cell carcinoma patients: a population-based study

 

N

Death from RCC (%)

Did not die from RCC (%)

p-value*

Mean age

370

62 (±13)

62 (±12)

0.62

Gender

    

Male

227

41 (18)

186 (82)

0.67

Female

143

23 (16)

120 (84)

 

Year of diagnosis

   

< 0.001

1971–1975

26

8 (31)

18 (79)

 

1976–1980

27

9 (33)

18 (67)

 

1981–1985

45

10 (22)

35 (88)

 

1986–1990

36

10 (28)

26 (82)

 

1991–1995

59

12 (20)

47 (75)

 

1996–2000

79

9 (11)

72 (89)

 

2001–2005

96

6 (8)

90 (92)

 

Diagnosis

   

< 0.001

Incidental

165

18 (11)

147 (89)

 

Symptomatic

205

46 (22)

159 (78)

 

Laterality**

   

0.004

Right kidney

205

28 (14)

177 (86)

 

Left kidney

165

36 (22)

129 (78)

 

Mean ESR (mm/h)

 

21.0 (±24)

38.8 (±40)

< 0.001

T stage

   

< 0.001

T1a

144

7 (5)

137 (95)

 

T1b

124

22 (18)

102 (82)

 

T2a

76

24 (32)

52 (68)

 

T2b

26

11 (42)

15 (58)

 

Tumor size (cm)

 

5.1 (±2.9)

7.6 (±3.1)

< 0.001

Histological RCC subtype

   

0.21

Clear cell

315

56 (18)

256 (82)

 

Papillary

42

8 (19)

34 (81)

 

Chromophobe

11

0 (0)

11 (100)

 

Other

2

0 (0)

2 (0)

 

Nuclear grade

   

< 0.001

I - II

299

40 (14)

259 (85)

 

III - IV

71

24 (34)

47 (66)

 
  1. Number of patients is given with percentage in parentheses, except for ESR and age where mean with standard deviation is given.
  2. *Mann-Whitney test for means, Chi-square for trends.